WP1: Legal and ethical framework for oncologic imaging
This WP will
- Define the overall legal and ethical scope, issues and requirements of the EuCanImage platform to ensure a privacy-by-design approach to its development.
- Establish a legal governancefor transnational and transcontinental health data transactions to guarantee the compliance of platforms operations across jurisdictions.
- Establish internal and external policies to govern interactions between data owners, users and data processors in the platform.
- Establish a novel ethical framework for developing and utilising AI-supported image-based decision support tools in clinical oncology.
- Evaluate and deploy new cost-effective incentives for data owners to share cancer imaging data in exchange for value in the area of cancer care, while addressing societal, legal and economic concerns.
WP2: Clinical use cases, requirements and feedback
This WP will
- Gather clinical requirements from the clinical partners, in collaboration with the data management and AI experts, on data management, AI development and AI assessment.
- Use, evaluate and optimise the data deposition, curation and enhancement capabilities of the platform.
- Design and implement AI solutions for the clinical use cases, and continuously refine them based on clinical feedback.
- Assess the AI solutions from both technical and clinical perspectives.
- Gather feedback from user experience, then provide recommendations and guidelines
WP3: Data platform and catalogue for cancer imaging and non-imaging data
This WP will
- Define the overall legal and ethical scope, issues and requirements of the EuCanImage platform to ensure a privacy-by-design approach to its development.
- Establish a legal framework for transnational and transcontinental health data transactions to guarantee the compliance of platforms operations across jurisdictions.
- Establish internal and external policies to govern interactions between data owners, users and data processors in the platform.
- Establish a novel ethical framework for developing and utilising AI-supported image-based decision support tools in clinical oncology.
- Evaluate and deploy new cost-effective incentives for data owners to share cancer imaging data in exchange for value in the area of cancer care, while addressing societal, legal and economic concerns.
WP4: Suite for cancer imaging data curation, annotation and enhancement
This WP will
- Create a comprehensive suite of open source tools and procedures for data anonymization that meet the legal requirements of all EU partners.
- Integrate an existing cloud-based tool for collaborative and user-friendly annotation of cancer imaging data.
- Expand POSDA tools and curation procedures to curate labelled data and non-imaging data.
- Further enhance the wealth of the available data through synthetic image generation.
- Implement tools for standardising image data cross sites and scanners.
- Leverage the large-scale data and machine learning to provide semi-automated capabilities for data curation and annotation.
WP5: Artificial intelligence development platform and interfaces
This WP will
- Provide the baseline compute environment to build flexible AI solutions for cancer imaging.
- Build a comprehensive and scalable cancer radiomics library.
- Implement a comprehensive machine learning toolbox for building integrative AI solutions.
- Ensure the machine learning techniques can be executed in a distributed privacy-preserving manner.
- Develop and validate tools for allowing the interpretability of AI-based decision.
- Establish and document in detail the FUTURE Guiding Principles for AI in cancer imaging.
WP6: Open-access platform for assessing and benchmarking AI solutions in cancer imaging
This WP will
- Achieve multi-stakeholder consensus with experts on metrics and criteria to assess and benchmark AI solutions.
- Develop methods to estimate bias and uncertainty, as well as procedures to handle errors in AI for cancer imaging based on ensemble and online learning.
- Develop new methods to assess the degree of interpretability of AI models.
- Propose guidelines to assess clinical effectiveness and usability of AI solutions in clinical oncology.
- Develop an open-access and disease-specific tool to evaluate cost-effectiveness of the AI products.
- Integrate the assessment methods and procedures for community auditing and benchmarking within ELIXIR’s OpenEBench platform.
WP7: Project dissemination, communication & exploitation
This WP will
- Develop EuCanImage’s corporate identity, as well as dissemination material.
- Develop and iteratively update a plan for dissemination and communication.
- Disseminate the project and its results to clinical, research and industrial stakeholders, as well as to the wider public.
- Establish the network of image-based cancer researchers, clinicians and innovators.
- Establish a plan for the exploitation and sustainability of the EuCanImage platform.
WP8: Scientific coordination and project management
This WP will
- Monitor the successful implementation of research activities (WPs 1-7) within the agreed time, cost and quality limits, including management of risks and corrective actions.
- Facilitate full synergy and interaction among EuCanImage partners by managing the internal channels, managerial committees, regular online and face-to-face meetings and project events.
- Coordinate and manage all administrative, financial and contractual aspects related to the project.
- Identify any upcoming risk as early as possible and work on mitigation plans and solutions.
- Create synergies with other initiatives in the field and/or part of this call and in the field of cancer/imaging across Europe and the world.
WP9: Ethics requirements
This work package sets out the ethics requirements definded by the European Commision that the project must comply with.